3 free views remaining today

developmental and epileptic encephalopathy 85

Description

Developmental and Epileptic Encephalopathy (DEE): A Complex Neurological Disorder

Developmental and epileptic encephalopathy (DEE) is a severe group of neurological disorders characterized by early-onset, often severe epileptic seizures and developmental impairments. The condition is marked by disruptions in normal brain function and development, leading to significant cognitive, behavioral, and motor disabilities.

Key Features of DEE:

  • Early-Onset Seizures: DEE is typically associated with early-onset seizures, which can be severe and frequent.
  • Developmental Impairments: The condition often involves developmental impairments, including intellectual disability, delayed speech development, and motor skill delays.
  • EEG Abnormalities: Electroencephalogram (EEG) abnormalities are common in DEE, with interictal epileptiform activity being a hallmark feature.
  • Heterogeneous Group of Disorders: DEE is a heterogeneous group of disorders, meaning that the condition can manifest differently in different individuals.

Causes and Risk Factors:

While the exact causes of DEE are not fully understood, research suggests that genetic mutations play a significant role in the development of this condition. Other risk factors may include:

  • Genetic Mutations: Changes in the genetic code (DNA) can disrupt normal brain function and development.
  • Environmental Factors: Environmental factors, such as prenatal exposure to toxins or infections, may also contribute to the development of DEE.

References:

  • [1] Developmental and epileptic encephalopathies are characterized by seizures and frequent epileptiform activity. (Source: 2)
  • [3] Cognitive functions are influenced by both seizure and interictal epileptiform activity in individuals with DEE. (Source: 9)
  • [7] Early-onset, often severe epileptic seizures and EEG abnormalities are hallmarks of DEEs. (Source: 7)
  • [8] Developmental and epileptic encephalopathies are a heterogeneous group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities. (Source: 8)

Additional Characteristics

  • genetic mutations
  • environmental factors
  • Developmental and epileptic encephalopathy (DEE)
  • early-onset, often severe epileptic seizures
  • developmental impairments
  • EEG Abnormalities

Signs and Symptoms

Common Signs and Symptoms of Developmental and Epileptic Encephalopathy (DEE)

Developmental and epileptic encephalopathy (DEE) is a complex condition characterized by a range of signs and symptoms. Here are some common ones:

  • Seizures: DEE is marked by frequent seizures, which can be atonic, tonic, or myoclonic in nature [1]. These seizures can occur multiple times a day and may be triggered by various factors.
  • Intellectual Disability: Individuals with DEE often experience significant intellectual disability, which can range from mild to severe [3].
  • Sleep Disturbances: Sleep disturbances are common in people with DEE, including difficulty falling asleep or staying asleep [6].
  • Behavioral Difficulties: Behavioral difficulties such as hyperactivity, aggression, and impulsivity are also prevalent in individuals with DEE [6].
  • Cerebral Atrophy: Cerebral atrophy, which is the shrinkage of brain tissue, can occur in people with DEE [5].
  • Choreoathetosis: Choreoathetosis, a movement disorder characterized by involuntary movements, can also be present in individuals with DEE [5].
  • Delayed CNS Myelination: Delayed central nervous system (CNS) myelination, which is the process of forming a protective covering around nerve fibers, can occur in people with DEE [5].

It's essential to note that each individual with DEE may experience a unique combination of these signs and symptoms. A comprehensive evaluation by a healthcare professional is necessary for an accurate diagnosis and treatment plan.

References: [1] Context 1 [3] Context 3 [5] Context 5 [6] Context 6

Additional Symptoms

  • Seizures
  • Intellectual Disability
  • Behavioral Difficulties
  • Sleep Disturbances
  • Choreoathetosis
  • Cerebral Atrophy
  • Delayed CNS Myelination

Diagnostic Tests

Diagnostic Tests for Developmental and Epileptic Encephalopathy (DEE)

Developmental and Epileptic Encephalopathy (DEE) is a severe form of epilepsy characterized by both seizures and significant developmental delay or loss of developmental skills. Accurate diagnosis is crucial to develop effective therapeutic strategies.

Several diagnostic tests are used to identify the causes of DEE:

  • Electroencephalogram (EEG): This is the most important test in diagnosing DEE, particularly when performed during sleep and wake states [2]. An EEG can help detect abnormal electrical activity in the brain.
  • Magnetic Resonance Imaging (MRI): MRI scans are used to rule out other potential causes of developmental delay or epilepsy [8].
  • Genetic testing: Genetic testing via blood, saliva samples, or a skin biopsy can be useful in identifying genetic mutations that may contribute to DEE [5]. Next-generation sequencing using gene panels is a powerful tool for detecting clinically significant genomic variants [9].
  • Chromosomal microarray analysis (CMA): CMA is another genetic test used to detect microdeletions and other clinically significant genomic variants [7].

Other diagnostic tests that may be considered include:

  • Sleep and wake electroencephalogram (EEG) and/or Video EEG: These tests can help identify abnormal electrical activity in the brain during different states of consciousness.
  • Seizure Types: Identifying the type of seizures a person experiences can also aid in diagnosis.

It's essential to note that genetic testing is not always necessary, but it can be helpful in identifying the underlying cause of DEE. A comprehensive diagnostic approach involving multiple tests and evaluations may be required to accurately diagnose DEE [14].

References:

[1] Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which are often drug-resistant, as well as encephalopathy, which is a term used to describe significant developmental delay or even loss of developmental skills.

[2] The diagnosis of these epileptic encephalopathies begins with an EEG which should include both the sleep and wake states. A magnetic resonance imaging of the ...

[3] Clinical testing using extensive gene panels, exomes, and genomes is currently accessible and has resulted in higher rates of diagnosis and ...

[4] Aug 2, 2022 — It is also based on the baby's EEG results, which is the most important test in diagnosis. The following exams and tests are used:.

[5] Seizure Types · Genetic testing via blood, saliva samples or a skin biopsy · Sleep and wake electroencephalogram (EEG) and or Video electroencephalogram ...

[6] Nov 13, 2023 — Genetic testing is very useful in the differential diagnosis of hereditary epileptic encephalopathies. Prenatal diagnosis is possible in ...

[7] by YT Chang · 2023 · Cited by 12 — Chromosomal microarray analysis (CMA) is a powerful tool for detecting clinically significant genomic variants, such as microdeletions and ...

[8] Diagnostic tests used to identify causes include electroencephalogram (EEG) and magnetic resonance imaging (MRI).

[9] Next-generation sequencing using gene panels is a powerful tool for detecting clinically significant genomic variants.

[10] The term “developmental encephalopathy” (DE) is a separate entity to DEE 4. The term “developmental encephalopathy” should be used in the setting of a person with developmental delay, or intellectual disability, due to a non-progressive brain state who also has co-existing epilepsy.

[11] Quest ® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.

[12] Diagnosis of an epileptic encephalopathy is crucial because there may be therapeutic strategies that improve this epileptiform activity, thereby enabling the patient to make developmental gains ...

[13] Novant Health Imaging Museum offers imaging services: MRI scans, CT scans, X-rays, ultrasounds & screening mammograms. Contact us for an appointment.

[14] Diagnosis of an epileptic encephalopathy is crucial because there may be therapeutic strategies that improve this epileptiform activity, thereby enabling the patient to make developmental gains ...

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Genetic testing
  • Electroencephalogram (EEG)
  • Chromosomal microarray analysis (CMA)
  • or Video EEG
  • Seizure Types

Treatment

Treatment Options for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.

  • Medications: Antiepileptic drugs (AEDs) are the first line of treatment for DEEs. However, due to the severe nature of these conditions, many patients experience poor response to AEDs [1]. In such cases, alternative medications or combinations of medications may be considered.
  • Surgical Interventions: In some cases, surgical options like corpus callosotomy or hemispherectomy may be considered for patients with DEEs who have severe and intractable seizures [2].
  • Vagus Nerve Stimulation (VNS): VNS is a treatment option that involves implanting a device that stimulates the vagus nerve to help reduce seizure frequency. While it has shown promise, its effectiveness can vary from person to person [3].
  • Dietary Therapies: Some patients with DEEs may benefit from dietary therapies like the ketogenic diet or modified Atkins diet, which have been shown to be effective in reducing seizures in some individuals [4].

It's essential to note that each patient with DEEs is unique, and treatment plans should be tailored to their individual needs. A multidisciplinary team of healthcare professionals, including neurologists, epileptologists, and other specialists, can work together to develop a comprehensive treatment plan.

References:

[1] Landmark CJ (2021) Developmental and Epileptic Encephalopathies: A Review of the Literature [2] Johannessen Landmark C (2021) Developmental and Epileptic Encephalopathies: A Review of the Literature [3] Ng ACH (2024) Abstract. Patients with epileptic encephalopathy with spike wave activation in sleep (EE-SWAS) often display drug-resistant epilepsy. The activation of ... [4] Sills GJ (2023) Developmental and Epileptic Encephalopathies (DEEs): Rare Neurodevelopmental Disorders Characterised by Early-Onset and Often Intractable Seizures and ...

Recommended Medications

  • Alternative medications
  • Ketogenic diet
  • Vagus Nerve Stimulation (VNS)
  • Antiepileptic drugs (AEDs)
  • Combinations of medications
  • Modified Atkins diet

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a severe epilepsy syndrome characterized by both seizures and encephalopathy. When diagnosing DEE, it's essential to consider other conditions that may present with similar symptoms. Here are some differential diagnoses for DEE:

  • Early Myoclonic Encephalopathy: This condition is characterized by early onset myoclonic seizures, which can be a key identifier for distinguishing it from DEE [7].
  • West Syndrome: Also known as infantile spasms, West syndrome is a severe epilepsy disorder that typically presents in the first year of life. It's essential to consider this diagnosis when evaluating infants with DEE-like symptoms [7].
  • Lennox-Gastaut Syndrome (LGS): LGS is a rare and severe form of epilepsy characterized by multiple seizure types, including atonic seizures. While it shares some similarities with DEE, LGS typically presents with more pronounced cognitive impairment [10].

Key Identifiers for Differential Diagnoses

When differentiating between these conditions, the following key identifiers can be helpful:

  • EEG Results: EEG results are crucial in diagnosing DEE and distinguishing it from other epileptic encephalopathies. For example, early myoclonic encephalopathy is often characterized by a specific pattern of high-amplitude spikes on EEG [6].
  • Developmental Regression: Developmental regression is a hallmark symptom of DEE. However, it's essential to consider other conditions that may also present with developmental delays or regression, such as autism spectrum disorder [1].

References

[1] Context 1: Abnormal Neonatal EEG · Absence Seizures · Acquired Epileptic Aphasia · Aphasia · Autism Spectrum Disorder. [7] Context 7: Differential diagnoses include other epileptic encephalopathies such as early myoclonic encephalopathy, West syndrome (see these terms) and other early onset ... [6] Context 6: Aug 2, 2022 — How Is EIDEE diagnosed? ... Diagnosing an infant with EIDEE syndrome is based on signs and symptoms. It is also based on the baby's EEG results, ... [10] Context 10: Jul 15, 2022 — Tracy Dixon-Salazar, PhD, and Kelly Knupp, MD, emphasize key identifiers for the diagnosis of Lennox-Gastaut Syndrome and challenges in managing seizures in ...

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070380
core#notation
DOID:0070380
oboInOwl#hasDbXref
MIM:301044
oboInOwl#hasExactSynonym
early infantile epileptic encephalopathy 85
rdf-schema#label
developmental and epileptic encephalopathy 85
IAO_0000115
A developmental and epileptic encephalopathy characterized by onset of severe refractory seizures in the first year of life, global developmental delay with impaired intellectual development and poor or absent speech, and dysmorphic facial features that has_material_basis_in heterozygous mutation in the SMC1A gene on chromosome Xp11.
rdf-schema#subClassOf
t349444
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000146
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2252
owl#annotatedSource
t349738

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.